Visit https://www.aetna.com/provweb/ to register to e-mail your requests for a faster response.
Medical Exception / Precertification* Request Form For Prescription Medications Please complete form and fax to: 1-800-408-2386 or call 1-800-414-2386. Visit https://www.aetna.com/provweb/ to register to e-mail your requests for a faster response. Visit www.aetna.com/formulary to access the Pharmacy Coverage Policy Bulletins.
Physician Signature (REQUIRED)
Please circle Antihistamine requested: ALLEGRA ALLEGRA-D CLARINEX SEMPREX-D ZYRTEC ZYRTEC-D What is the patient’s diagnosis? (circle all that apply) Allergic Rhinitis Chronic Idiopathic Urticaria Other _____________________ List previous therapy, including OTCs: _______________________________________Dates (if available) __________________________ Response to previous therapy (circle all that apply) Inadequate response Adverse effect(s) Comments ___________________________
Please circle Proton Pump Inhibitor requested: ACIPHEX NEXIUM PREVACID PRILOSEC PROTONIX omeprazole (generic) What dosage is being requested? _____mg
What is the patient’s diagnosis? (circle all that apply) GERD Nocturnal acid breakthrough
Barrett esophagus Hypersecretory condition
List previous therapy, with dates: ______________________________________________________________________________________ Response to previous therapy (circle all that apply) Inadequate response Adverse effect(s) Comments __________________________
Please circle COX-IISelective Inhibitor requested:
What is the patient’s diagnosis? (circle all that apply) Osteoarthritis
List previous therapy, with dates: _____________________________________________________________________________________ Response to previous therapy (circle all that apply) Inadequate response Adverse effect(s) Comments ___________________________ Does the patient have a history of peptic ulcer disease or NSAID-related ulcer/GI bleeding?
Is the patient currently using anticoagulants, antiplatelets, or corticosteroids?
Please circle Antifungal requested: DIFLUCAN
What is the patient’s diagnosis? (circle all that apply) Onychomycosis Vulvovaginal Candidiasis Oral Candida (thrush)
Candida (esophageal, intestinal, UTI, other)
List previous therapy, with dates: _____________________________________________________________________________________ Response to previous therapy (circle all that apply) Inadequate response Adverse effect(s) Comments ___________________________ FOR ONYCHOMYCOSIS: KOH, PAS, fungal culture results: _______ Test Date:__________ Location? Fingernail(s) Toenail(s) What other conditions does patient have? (circle all that apply) Pain Limiting Activity Diabetes Mellitus Immunosuppression (AIDS, cancer, etc.) Systemic dermatosis
Peripheral vascular disease Other _______________
If prior onychomycosis therapy, please note: Drug: ________________ Start Date: ___________
Response to previous therapy (circle all that apply) Inadequate response Adverse effect(s) Comments __________________________
Accutane, isotretinoin What is the patient’s diagnosis? _______________________________________________________________________________________ P revious therapy: (circle all that apply) doxycycline
Other _____________________________________
Response to previous therapy (circle all that apply) Inadequate response Adverse effect(s) Comments ____________________________ If female, pregnancy test results: __________________
Test Date: ______________________________
For ALL other precertification/medical exception requests Drug requested: ______________________________ Duration of therapy requested: ___________________________________ Diagnosis: __________________________________________________________________________________________________________ Previous therapy(ies) received, with duration: ____________________________________________________________________________ Previous therapy(ies) with inadequate therapeutic response ____________________________________________________________________ Previous therapy(ies) causing adverse effects _______________________________________________________________________________ Therapy(ies) contraindicated in patient ____________________________________________________________________________________
*The term precertification means the utilization review process to determine whether the requested service, procedure, prescription drug or medical device meets the company’s clinical criteria for coverage. IT does not mean precertification as defined by Texas law, as a reliable representation of payment of care or services to fully insured HMO and PPO member.
The Ne w E n g l a nd Jo u r n a l o f Me d ic i neAndrogens are important in regulating hair growth. At puberty, androgens increase the size of follicles inthe beard, chest, and limbs and decrease the size ofA L A S T A I R J . J . W O O D , M . D. , Editor follicles in the bitemporal region, which reshapes thehairline in men and many women. ANDROGENETIC ALOPECIA TREATMENT OF HAIR LOSS
H C V F A C T S H E E T F O R P A T I E N T S P R A C T I C E S U P P O R T T O O L K I T TRIPLE THERAPY FOR CHRONIC HEPATITIS C In May 2011, two new drugs to treat chronic hepatitis C (HCV) were approved by the FDA. Telaprevir (Incivek) and boceprevir (Victrelis) are protease inhibitors that interfere with the ability of the HCV virus to multiply. These new drugs are ONLY for patients